Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 29, 2011 Arundhati Parmar	Medtronic Stands to Gain From Likely CMS Reversal on MRI-Safe Pacemakers Is this a big opportunity for Medtronic?
The Motley Fool June 29, 2005 Stephen D. Simpson	Medtronic Makes a Fat Deal Medtronic's purchase of the developer of an "obesity pacemaker" could reap rewards in a few years. Investors, take note.
The Motley Fool October 16, 2007 Billy Fisher	A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low.
The Motley Fool December 29, 2011 Harsh Chauhan	Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now.
The Motley Fool May 12, 2011 Arundhati Parmar	Analysts: Medtronic CEO Omar Ishrak Good Choice Ishrak represents a change at Medtronic.
The Motley Fool December 9, 2011 Harsh Chauhan	Medtronic Regains Its Footing Medtronic comes up with a strong quarter.
The Motley Fool November 21, 2006 Ryan Fuhrmann	Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already?
BusinessWeek July 5, 2004 Michael Arndt	High Tech -- And Handcrafted Despite a recent recall, medical-products maker Medtronic sets the quality standard for heart care.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool August 6, 2011 Arundhati Parmar	Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets.
The Motley Fool October 23, 2006 Michael P. Cecil	Are Pacemaker Prices Heading for a Fall? Medicare law changes may drive the amount that hospitals can pay for pacemakers. Will device makers be forced to lower prices? Investors, take note.
The Motley Fool February 5, 2008 Brian Orelli	Medtronic Endeavors to Compete The U.S. drug-eluting stent market just got a little more crowded, after Medtronic announces that the FDA had approved its Endeavor stent for marketing in the U.S.
IndustryWeek April 1, 2008 Nick Zubko	Price Check on Manufacturing A benchmarking survey polled more than 500 pricing professionals in manufacturing, distribution and industrial services to shed light on their methods, perceptions and trends in pricing practices and capabilities.
The Motley Fool April 30, 2011 Arundhati Parmar	iPad Makes Medtronic More Than Just Cool Roughly 5,000 Apple iPads being used within Medtronic have kept the world's largest medical device company pretty busy developing apps.
The Motley Fool May 21, 2008 Brian Orelli	Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue.
The Motley Fool February 20, 2008 Brian Orelli	Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future.
The Motley Fool November 24, 2009 Brian Orelli	52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool July 13, 2011 Arundhati Parmar	FDA OKs Study Design on Medtronic Product That Firm Is Bullish On The product is the Simplicity catheter-based system to treat hypertension, or high blood pressure.
The Motley Fool August 22, 2007 Ryan Fuhrmann	Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
BusinessWeek May 29, 2006 Gene G. Marcial	Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast.
The Motley Fool August 20, 2008 Brian Orelli	Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market.
The Motley Fool May 24, 2007 Ryan Fuhrmann	Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations.
The Motley Fool May 3, 2011 Arundhati Parmar	Medtronic Is Target of New Senate Finance Committee Investigation The Senate scrutiny comes at a time when both parties are looking at entitlement reform, including how to overhaul Medicare and Medicaid.
The Motley Fool February 24, 2010 Brian Orelli	Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products.
The Motley Fool November 17, 2010 Bryan Hinmon	Rising Star Buy: Medtronic Find out why this medical technology giant takes a place in our Un Portfolio.
The Motley Fool August 18, 2008 Brian Orelli	Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%.
The Motley Fool July 6, 2007 Billy Fisher	Medtronic: For the Broken-Hearted Promising clinical trial could bring a new Medtronic stent to market. Investors, take note.
The Motley Fool March 3, 2011 Bryan Hinmon	Medtronic's Moat Is Strengthening Lessons from an interview with Medtronic CFO Gary Ellis.
CIO January 26, 2012 Kim S. Nash	Pricing Done Right Setting prices is a strategic decision that needs C-level attention. Your profits depend on it.
IndustryWeek August 18, 2010 Wilbur Reid	Consider This -- Why Companies Need a Chief Pricing Officer In the new order, the rise of strategic pricing roles such as a chief pricing officer and supporting pricing team will help companies achieve strong financial performance.
The Motley Fool March 2, 2011	Fool Q&A: Medtronic CFO Gary Ellis The medical-device maker's chief financial officer talks R&D, "One Medtronic," and growth in emerging markets.
The Motley Fool August 25, 2009 Brian Orelli	Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again.
The Motley Fool November 18, 2011 Brian Orelli	Medtronic: Cutting Fat and Growing Margins The company announces that it has sold Physio-Control to private-equity fund Bain Capital.
The Motley Fool February 17, 2005 Stephen D. Simpson	Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock?
AskMen.com	Fake Study, Real Paycheck Medical device maker Medtronic paid about $850,000 over nearly 10 years to a former Army surgeon accused of forging signatures and falsifying data for a study touting the benefits of one of the company's implants.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
The Motley Fool May 26, 2004 Alyce Lomax	Medtronic Takes Heart After the stock drops on data, what does the company have to say?
BusinessWeek October 29, 2007 Arlene Weintraub	Medtronic's Uncertain Endeavor The drug-coated stent might have made up for Medtronic's recent product recall, but renewed scrutiny of the device has executives scaling back expectations
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
The Motley Fool May 25, 2010 Brian Orelli	Medtronic Gets Tossed Out With the Bathwater A bad day to report good news.
The Motley Fool August 18, 2011 Todd Wenning	What Does Medtronic Do With Its Free Cash? Is it a good steward of shareholder capital?
The Motley Fool August 31, 2011 Harsh Chauhan	Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion.
The Motley Fool November 9, 2005 Stephen D. Simpson	Greatbatch Keeps Growth Pumping Demand for implantable medical electronics keeps this battery and component maker humming. Investors new to this stock and/or medical technology in general will need to exercise some patience.
The Motley Fool November 18, 2004 W.D. Crotty	Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy.
The Motley Fool August 6, 2010 Bryan Hinmon	Moat Report Card: Medtronic This medical supplier's definitely got a heartbeat.
The Motley Fool October 22, 2011 Harsh Chauhan	This Stock May Be a Surprisingly Good Buy Medtronic's moves could reap dividends in the future.